NOVARTIS AG

Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare. They have over 104,323 employees worldwide as on 2021.

Annual Results Summary:

Novartis AG - Yearly Revenues and Profits - in Billion USD:

Year - Ending	Revenue	Operating Income	Net Profit
Dec-2022	51.83	9.19	6.95
Dec-2021	52.87	11.68	24.02
Dec-2020	49.89	10.15	8.07
Dec-2019	48.67	9.08	11.73
Dec-2018	53.16	8.17	12.61
Dec-2017	50.13	8.63	7.70
Dec-2016	49.43		6.71

Balance Sheet Summary

Novartis AG - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2022	117,453	58,030	59,423
Dec-2021	131,795	64,140	67,655
Dec-2020	132,059	75,461	56,598
Dec-2019	118,370	62,896	55,474
Dec-2018	145,563	66,949	78,614
Dec-2017	133,079	58,911	74,168

Quarterly Results Summary:

Novartis AG - Quarter wise Revenues and Profits - in Million USD:

Quarter - Ending	Revenue	Net Profit
Dec-2022	13,087	1,466
Sep-2022	12,842	1,573
Jun-2022	13,085	1,694
Mar-2022	12,814	2,222
Dec-2021	13,522	16,308
Sep-2021	13,367	2,758
Jun-2021	13,294	2,896
Mar-2021	12,694	2,059
Dec-2020	13,030	2,094
Sep-2020	12,259	1,932
Jun-2020	11,347	1,867
Mar-2020	12,078	2,176
Dec-2019	12,716	1,125
Sep-2019	12,172	2,041
Jun-2019	12,024	6,799
Mar-2019	11,455	1,766

NOVARTIS AG

Novartis AG - Yearly Revenues and Profits - in Billion USD:

Novartis AG - Balance Sheet Summary - in Million USD:

Novartis AG - Quarter wise Revenues and Profits - in Million USD:

Share it on Social Media